Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11055
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Prowle, John R | en |
dc.contributor.author | Bellomo, Rinaldo | en |
dc.date.accessioned | 2015-05-16T00:38:02Z | |
dc.date.available | 2015-05-16T00:38:02Z | |
dc.date.issued | 2010-08-01 | en |
dc.identifier.citation | Current Opinion in Critical Care; 16(4): 332-6 | en |
dc.identifier.govdoc | 20543683 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | http://ahro.austin.org.au/austinjspui/handle/1/11055 | en |
dc.description.abstract | Intravenous fluids are widely administered in the ICU with the intention of preventing or ameliorating acute kidney injury (AKI). This review focuses on recent studies examining fluid administration and renal function in critical illness to critically examine conventional justifications for fluid administration.Early, targeted, resuscitation of inadequate cardiac output in shock may have a beneficial effect on organ function and patient outcome. However, experimental evidence suggests the relationship between fluid administration and an increase in renal oxygen delivery is weak, whereas any beneficial effects from fluid administration can be short lived. Conversely, evidence associating fluid overload and adverse outcomes is strengthening, whereas more restrictive fluid administration does not seem to predispose to clinically significant AKI in many situations. Furthermore, concerns persist that some colloid or high chloride concentration solutions may directly impair renal function independent of volume overload.Adequate volume resuscitation remains a cornerstone to the emergent treatment of critical illness. However, continued fluid administration and positive fluid balances have not been shown to improve renal outcomes and may worsen overall prognosis in AKI. Concerns about renal dysfunction should not deter clinicians from adopting more restrictive approaches to fluid administration. | en |
dc.language.iso | en | en |
dc.subject.other | Cardiac Output | en |
dc.subject.other | Critical Care.methods | en |
dc.subject.other | Critical Illness | en |
dc.subject.other | Fluid Therapy.methods | en |
dc.subject.other | Glomerular Filtration Rate | en |
dc.subject.other | Hemodynamics | en |
dc.subject.other | Humans | en |
dc.subject.other | Infusions, Intravenous.methods | en |
dc.subject.other | Intensive Care Units | en |
dc.subject.other | Isotonic Solutions.administration & dosage | en |
dc.subject.other | Kidney.physiology | en |
dc.subject.other | Prognosis | en |
dc.subject.other | Shock, Cardiogenic.prevention & control | en |
dc.title | Fluid administration and the kidney. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Current opinion in critical care | en |
dc.identifier.affiliation | Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.doi | 10.1097/MCC.0b013e32833be90b | en |
dc.description.pages | 332-6 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/20543683 | en |
dc.type.austin | Journal Article | en |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Journal Article | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.